Beijing Med-Pharm Co., Ltd. Announces Approval for Listing on the NASDAQ Global Market

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Beijing Med-Pharm Corporation (Nasdaq:BJGP) today announced that it has secured approval from NASDAQ to transfer the listing of its common stock from the NASDAQ Capital Market to the NASDAQ Global Market effective at market open today. Beijing Med-Pharm common stock began trading on the NASDAQ Capital Market in August 2006. The company’s common stock will continue to trade under its current symbol, BJGP.